Experimental cancer drug trial halted early

NCT ID NCT05159388

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new drug called PRS-344/S095012 in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The trial was stopped early, and only 46 people took part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cabrini Oncology Research

    Malvern, Victoria, Australia

  • Carolina Bio Oncology

    Huntersville, North Carolina, 28078, United States

  • Chris O'Brian Lifehouse

    Camperdown, Australia

  • Hospital Universitario Gregorio

    Madrid, Spain

  • Hospital Vall d'Hebron

    Barcelona, Spain

  • Institute Jules Bordet

    Brussels, Belgium

  • NEXT Oncology

    San Antonio, Texas, 78229, United States

  • START

    Madrid, 28050, Spain

  • The Queen Elizabeth Hospital

    Woodville South, Australia

  • U.Z. Gent Medical Oncology

    Ghent, Belgium

  • Universitair Ziekenhuis

    Edegem, Belgium